Tagged with

Mexico Alexis Serlin, country president of Novartis Mexico and president of CANIFARMA, the industry chamber that brings together multinational and local drug manufacturers, explains how the pharmaceutical industry in Mexico aims to be recognized as a strategic sector by both the Ministries of Health and Economy. He highlights Novartis Mexico’s leadership in…

Luxembourg CEO Marc Vandelaer reveals why the Luxembourg biobank IBBL is more than a traditional biobank and how, despite the short time since its inception in 2010, it has begun to receive recognition as a leader within the biobanking industry and a valued bioservice provider. IBBL (Integrated BioBank of Luxembourg) has…

Mexico The General Directors of Rayere explain how the historical Mexican pharma company has been leveraging its outstanding manufacturing capacity and product development expertise to become a thriving and reputed player in the patented segment, while the company now envisions to bring its high-quality quality products to international markets. Rayere boasts…

Singapore Mundipharma’s president of Asia Pacific, Latin America, and the Middle East and Africa, Raman Singh defines the underlying drivers behind the company’s explosive growth, while sharing his insights on what it takes for pharma companies to truly succeed in modern-day emerging markets. He also elaborates on Mundipharma’s recent decision to…

Mexico Carlos Abelleyra Cordero, CEO Spanish Latin America of Aspen Labs, describes the rapid development of Aspen’s operational capacity throughout the region, in line with the company’s ambition to ultimately establish itself as the commercial partner of choice of big pharma companies in Latin America. He also documents Aspen’s focus on…

Singapore The French ambassador to Singapore showcases the importance of the Asian country to France as a regional hub, the footprint of the French business community in the Singaporean economy, and Singapore’s aim to tailor its R&D efforts. In terms of foreign relations, how strategically important is Singapore to France? More…

Ireland Niall Barron, director of the NICB, discusses the Institute’s research, which has included significant research into Chinese Hamster Ovary (CHO) cell engineering and the identification of micro-RNA mechanisms that can triple protein yields in some limited cases. Could you please introduce the NICB to our global readers and the Institute’s…

Mexico Karel Fucikovsky, general director PFM Latin America at Pierre Fabre, on the strategic focus of the company on operational and commercial excellence in Mexico and Latin America, which both stand as strategic areas for the international growth of the group. He also highlights the main growth opportunities and market challenges the…

Switzerland’s especially fine reputation for research impact and innovation generation is attracting a host of MNCs to base their European headquarters in the mountain nation and spend big on world-leading cutting-edge R&D. “Switzerland represents an extremely fertile ground for scientific findings” Walter Steinlin, CTI According to the yearly European and…

Ireland Geraldine Freeman, Commercial Director at Johnson & Johnson Consumer Business in Ireland, discusses the increasing trend towards self-care in Ireland and the importance of the self-care agenda within the context of rising healthcare expenditures; the strong legacy of Johnson & Johnson in Ireland with leadership positions across most market segments;…

In an exclusive interview, Dr. José Narro Robles, Secretary of Health of Mexico, provides insight into the main challenges of the domestic healthcare system and his strategic priorities to improve the quality of life for Mexican citizens, while highlighting his commitment to better leveraging the financial resources of a public…

Switzerland Thomas Cueni of Interpharma, the Association of Pharmaceutical Research Companies of Switzerland, on the trend of major international companies developing significant operations in Switzerland; how 70 percent of employees at the top pharma companies are foreigners; and why the pharmaceutical industry is the exception to the rule when it comes…